Dr Reddy's Labs launches copy of BI drug; move may lead to legal battle
![](https://img.etimg.com/thumb/msid-87098082,width-1070,height-580,imgsize-9342,overlay-economictimes/photo.jpg)
Under its brand Vicra, Dr. Reddy's is expected to sell the drug in India at less than a third of the price charged by Boehringer Ingelheim. According to sources the 10 mg variant of Dr. Reddy's brand may cost ₹15 per tablet against ₹51 of the innovator's brand.
via Economictimes
Post a Comment